Bal Pharma Ltd Annually Results

Gross Sales

339.22

304.22

281.21

250.53

171.09

Excise Duty

0

0

0

0

0

Net Sales

339.22

304.22

281.21

250.53

171.09

Other Operating Income

0

0

0

0

0

Other Income

2.85

0.98

5.15

1.14

1.85

Total Income

342.07

305.19

286.37

251.67

172.95

Total Expenditure

307.69

278.82

257.74

226.07

166.35

PBIDT

34.38

26.37

28.63

25.6

6.6

Interest

15.26

12.49

10.41

11.97

12.45

PBDT

19.12

13.88

18.22

13.62

-5.85

Depreciation

10.07

9.13

9.04

9.52

7.68

Minority Interest Before NP

0

0

0

0

0

Tax

0.76

2.03

5.42

-0.61

-0.64

Deferred Tax

0.85

0.1

-1.94

0

0

Reported Profit After Tax

7.45

2.62

5.7

4.71

-12.89

Minority Interest After NP

0.05

0.05

0.09

-0.03

-0.67

Net Profit after Minority Interest

7.39

2.57

5.61

4.74

-12.22

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

7.39

2.57

5.61

4.74

-12.22

EPS (Unit Curr.)

4.94

1.67

3.79

3.34

-8.62

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

12

10

10

10

0

Equity

15.8

15.69

14.82

14.82

14.17

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

10.13

8.66

10.18

10.21

3.85

PBDTM(%)

5.63

4.56

6.47

5.43

-3.41

PATM(%)

2.19

0.86

2.02

1.88

-7.53